EUDA Health Holdings Limited (NASDAQ:EUDAW)
| Market Cap | 843.11K-78.2% |
| Revenue (ttm) | 11.76M+193.2% |
| Net Income | -4.76M+69.0% |
| EPS | -0.13+79.5% |
| Shares Out | 37.81M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47 |
| Open | 0.03 |
| Previous Close | 0.04 |
| Day's Range | 0.02 - 0.03 |
| 52-Week Range | 0.02 - 0.10 |
| Beta | 0.64 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 3, 2027 |
About EUDAW
EUDA Health Limited, established in Singapore in 2019, offers a digital healthcare platform that facilitates online consultations for minor health concerns. The firm functions as a subsidiary of Watermark Developments Limited.
$EUDAW stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in EUDAW holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by EUDAW's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
EUDAW Estimated quarterly lobbying spending
Source: U.S. Senate LDA
EUDAW Revenue by Segment or Geography
As of: Q1 2023 (Mar 31, 2023) · Source: SEC EDGAR (10-Q)
U.S. Patents
New EUDAW patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to EUDAW from public contracts
Source: USAspending.gov
EUDAW Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from EUDAW’s recent data — informational, not investment advice
